β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Cisplatin is one of the most used anticancer chemotherapy agents; however, over time, patients develop resistance to the treatment, and survival rates drop dramatically. Investigation of tumor cell resistance mechanisms could increase sensitivity and prevent cancer progression. Here, we investigated...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Wiley
2026-02-01
|
| Цуврал: | Molecular Oncology |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1002/1878-0261.70089 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|